Flanders.healthTech

Name

Flanders.healthTech

Legal name

Flanders.healthTech

Website

https://flandershealth.tech

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Health Technology

NAICS

Surgical and Medical Instrument Manufacturing (339112), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)

akta.pro secondary industries

Digital Health, Health Information Systems & Data Programs (BPADAIAJ), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Healthcare innovation projects
• AI medical imaging
• Preoperative simulation software
• Bioprocess development tools
• Collaborative medtech R&D

Headquarters

HQ city

Gent

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations

Core offering

Flanders.healthTech coordinates a portfolio of 14 collaborative healthcare innovation projects in Flanders, Belgium, developing AI-driven medical imaging analysis (jaw implant analysis), preoperative simulation tools (heart implant planning), and a biodevice toolbox for rapid bioprocess development. The initiative brings together companies, knowledge centers, and healthcare institutions to jointly develop and validate advanced health technologies.

Product overview

Flanders.healthTech is a healthcare innovation initiative comprising 14 collaborative projects focused on advanced medical technology development. The portfolio includes AI-driven jaw implant analysis for dental implant planning, preoperative heart-implant simulation for cardiac device procedures, and a biodevice toolbox for rapid bioprocess development. These projects are supported by EUR 4.7 million in funding from VLAIO and involve collaboration among companies, knowledge centers, and healthcare institutions across Flanders, Belgium.

Differentiator

Problem solved

Functional benefit

Products and services

• AI-driven Jaw Implant Analysis Artificial intelligence system that analyzes medical imaging data of jaw structures to support dental/maxillofacial implant planning, visualization, and assessment. Targeted at dental clinicians and surgeons.
• Preoperative Heart-Implant Simulation Computational simulation platform that enables preoperative modeling of heart implant procedures using patient-specific data, allowing cardiac surgeons to visualize and plan device implantation before surgery.
• Biodevice Toolbox Software toolkit designed for rapid bioprocess development, providing standardized tools and automated workflows to accelerate the creation and testing of biodevices for life sciences companies and research institutions.

Quantifiable outcome

• 14 healthcare innovation projects launched to strengthen Flanders' position in life sciences and health technology

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Healthcare institutions in FlanderscoreStrategic or Co-development PartnerHealthcare institutions participate as key partners in the collaborative innovation projects, providing clinical expertise, use cases, and validation environments for AI-driven medical technologies including jaw implant analysis and heart-implant simulation tools.
• Knowledge centers and research institutionscoreStrategic or Co-development PartnerAcademic and research institutions collaborate on the 14 innovation projects, contributing scientific expertise, research capabilities, and technology transfer opportunities in areas such as AI-driven healthcare analysis and bioprocess development.
• Companies in the life sciences and health technology sectorcoreStrategic or Co-development PartnerIndustry companies participate as partners in the collaborative innovation projects, contributing commercial expertise, development resources, and pathways to market for healthcare technologies including medical implants, AI diagnostic tools, and biodevices.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• MEDVIA: Flemish health tech industry-driven network cluster explicitly referenced in the company's own short description ('MEDVIA is an industry-driven network company'). Flanders.healthTech appears operationally connected to or operating under MEDVIA's cluster model, making it the closest direct peer in terms of mission, geography, and stakeholder architecture.
• BioWin: Walloon (Belgium) life sciences and health technology competitiveness cluster, comparable in being a publicly-funded regional innovation hub coordinating industry, academia, and hospitals — provides a directly comparable Belgian benchmark for cluster economics and grant-funded operating models.

Broad incumbents

• EIT Health: Pan-European health innovation network backed by the European Institute of Innovation & Technology. Comparable as a multi-stakeholder (industry-university-clinics) health innovation coordination body operating at a larger EU scale, providing a potential partnership, funding, or competitive benchmark.

Regional players

• CataloniaBio & HealthTech: Catalan (Spain) life sciences and health technology cluster connecting companies, research institutions, and hospitals. Structurally analogous as a regional cluster organization but operating in a different geography, useful as a comparator for cluster scaling and member ROI.
• BioCon Valley: German life sciences and health technology cluster serving Mecklenburg-Vorpommern and Brandenburg. Comparable as a publicly-supported regional health innovation hub aggregating SMEs, research institutes, and clinical partners around collaborative R&D projects.
• Health Capital Berlin Brandenburg: Cluster organization for the Berlin-Brandenburg healthcare industry, linking industry, science, and clinics. Comparable as a regional cluster coordination body with a similar multi-stakeholder and project-funding model.
• Lyonbiopole: French Auvergne-Rhône-Alpes life sciences cluster, formally labeled as a 'pôle de compétitivité.' Comparable as a regional, publicly-co-funded health innovation hub running collaborative R&D projects across diagnostics, medical devices, and biotech.
• Health Innovation Manchester: UK innovation accelerator embedded in the Greater Manchester health ecosystem, linking NHS providers, universities, and industry. Comparable as a regional health innovation hub driving adoption of new technologies through collaborative projects.
• Life Sciences Hub Wales: Welsh government-backed life sciences and health innovation hub connecting industry, health system, and academia. Comparable as a publicly-funded regional health tech cluster with a project-based model focused on economic and clinical impact.
• Zorginnovatie (Dutch healthcare innovation network): Dutch ecosystem initiative connecting healthcare innovators, providers, and payers. Comparable as a nearby (Netherlands) regional health innovation coordination entity, useful as a cross-border peer and potential partnership node given geographic proximity to Flanders.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Flanders.healthTech